Fda
-
Rapid antigen tests have reduced sensitivity against Omicron: US FDA
World | Dec 29, 2021, 02:33 PM ISTThe findings are based on a study conducted by the FDA in collaboration with the US National Institutes of Health.
-
Merck COVID pill effective, experts will review safety: FDA
World | Nov 26, 2021, 10:58 PM ISTThe FDA scientists said their review identified several potential risks, including possible toxicity and birth defects.
-
Zydus Cadila gets FDA's approval to market generic cancer drug in US
World | Nov 20, 2021, 03:54 PM ISTThe company has received final approval from the US Food and Drug Administration (USFDA) to Decitabine for Injection in the strength of 50 mg/vial single-dose vial, Zydus Cadila said in a statement.
-
FDA authorizes first e-cigarette, cites benefit for smokers
World | Oct 13, 2021, 12:38 PM ISTWhile the products can now be legally sold in the U.S., the FDA stressed they are neither safe nor “FDA approved,” and that people who don’t smoke shouldn’t use them.
-
Next on FDA’s agenda: Booster shots of Moderna, J&J vaccines
World | Oct 12, 2021, 08:19 PM ISTThe FDA meetings come as U.S. vaccinations have climbed back above 1 million per day on average.
-
US panel backs COVID-19 boosters only for seniors, high-risk
World | Sep 18, 2021, 06:47 AM ISTAn influential federal advisory panel overwhelmingly rejected a plan to offer Pfizer booster shots against COVID-19 to most Americans.
-
Anthony Fauci hopeful of COVID vaccines getting full OK by FDA within weeks
World | Aug 09, 2021, 08:12 AM ISTThe FDA has only granted emergency-use approval of the Pfizer, Moderna and Johnson & Johnson vaccines, but the agency is expected to soon give full approval to Pfizer.
-
Some in US getting COVID-19 boosters without FDA approval
World | Aug 08, 2021, 07:16 AM ISTAmericans have managed to get COVID booster shots by taking advantage of the nation’s vaccine surplus and loose tracking of those who have been fully vaccinated.
-
FDA adds warning of rare reaction risk to J&J Covid vaccine
World | Jul 13, 2021, 07:43 AM ISTUS regulators on Monday added a new warning to Johnson & Johnson's COVID-19 vaccine about links to a rare and potentially dangerous neurological reaction, but said it's not entirely clear the shot caused the problem.
-
We respect US's decision: Centre on Covaxin EUA rejection
India | Jun 11, 2021, 07:18 PM ISTBharat Biotech's application for approval of indigenous COVID-19 vaccine, Covaxin, has been rejected by the US FDA that cited a lack of sufficient data.
-
FDA expected to OK Pfizer vaccine for teens within week
World | May 04, 2021, 10:14 AM ISTFDA is expected to authorize Pfizer's COVID-19 vaccine for young adults age 12 and older by next week
-
Study identifies possible Covid drugs
Science | Apr 03, 2021, 02:55 PM ISTA team of researchers has identified nine potential new Covid-19 treatments, including three, that were already approved by the US Food and Drug Administration (FDA) for treating other diseases.
-
US FDA Hahn commissioner refuses to offer COVID-19 vaccine timing
World | Jul 06, 2020, 08:00 AM ISTCommissioner of the US Food and Drug Administration (FDA) Stephen Hahn has refused to offer a timeline for the COVID-19 vaccine, which US President Donald Trump suggested could be available "long before the end of the year".
-
US drug body FDA revokes Hydroxychloroquine status as emergency medicine to treat COVID-19
World | Jun 15, 2020, 11:33 PM ISTThe FDA said it was no longer reasonable to believe that oral formulations of hydroxychloroquine and the related drug chloroquine may be effective in treating the respiratory illness caused by the novel coronavirus.
-
FDA approves Dr Reddy's NDA for migraine drug
Business | May 06, 2020, 07:30 PM ISTDr Reddy's Laboratories Ltd said the companys NDA (new drug application) Elyxyb ((celecoxib oral solution 25 mg/mL) has been approved by the US Food and Drug Administration.
-
72 COVID-19 therapeutics trial underway, 211 in planning stages: FDA
World | Apr 25, 2020, 09:15 AM ISTA top Trump administration health official has said that as many as 19 therapeutics trial are underway and 211 in planning stages in a bid to find the cure for coronavirus.“We are leaving no stone unturned to find the treatment for COVID-19... We don't have any approved therapeutics for COVID-19 but we are actively involved with the academic, commercial and private sector to find it,” FDA Commissioner Stephen M Hahn told reporters at a White House news conference.
-
Hydroxychloroquine dangerous for heart ailments: FDA wans against side effects of malaria drug
World | Apr 25, 2020, 09:08 AM ISTFDA said as of now it has issued an emergency use authorisation to allow hydroxychloroquine and chloroquine products donated to the Strategic National Stockpile (SNS) to be distributed and used in limited circumstances, such as for certain hospitalised patients with COVID-19.
-
US FDA approves point-of-care test for coronavirus
World | Mar 22, 2020, 08:52 AM ISTThe US Food and Drug Administration on Saturday approved a coronavirus diagnostic test that can be conducted entirely at the point-of-care and can deliver results in 45 minutes.
-
FDA cracks down on sale, manufacture of substandard sanitisers
Business | Mar 13, 2020, 11:33 AM ISTWhile authorities in Maharashtra are busy curbing the spread of the novel coronavirus, some unscrupulous elements, who are looking to make a fast buck by selling substandard hand wash products and sanitisers, have come under the scanner of the state's health regulator.
-
Sindoor (Vermillion) used by married women in India could contain dangerous levels of lead, research says
Lifestyle | Aug 31, 2017, 03:56 PM ISTIn the study, 80% of the sindoor (vermillion) sample contained lead.